Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127796501 | 12779650 | 1 | I | 201608 | 20160919 | 20160926 | 20160926 | PER | US-PFIZER INC-2016442367 | PFIZER | 68.00 | YR | F | Y | 107.00000 | KG | 20160926 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127796501 | 12779650 | 1 | PS | AROMASIN | EXEMESTANE | 1 | Oral | 25 MG, 1X/DAY | Y | 20753 | 25 | MG | COATED TABLET | QD | |||||
| 127796501 | 12779650 | 2 | C | TRAMADOL. | TRAMADOL | 1 | Oral | 50 MG, 3X/DAY | 0 | 50 | MG | TID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127796501 | 12779650 | 1 | Breast cancer |
| 127796501 | 12779650 | 2 | Fibromyalgia |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127796501 | 12779650 | Depression | |
| 127796501 | 12779650 | Feeling abnormal | |
| 127796501 | 12779650 | Hyperhidrosis | |
| 127796501 | 12779650 | Hypersensitivity | |
| 127796501 | 12779650 | Insomnia | |
| 127796501 | 12779650 | Muscle spasms | |
| 127796501 | 12779650 | Thinking abnormal |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |